12 results for author:"Kusuhara M." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| ATP-binding cassette transporter A1 gene transcription is downregulated by activator protein 2alpha. Doxazosin inhibits activator protein 2alpha and increases high-density lipoprotein biogenesis independent of alpha1-adrenoceptor blockade. Iwamoto N., Abe-Dohmae S., Ayaori M., Tanaka N., Kusuhara M., Ohsuzu F., Yokoyama S. Circ. Res. 101:156-165(2007) · Mapped (17) |
| High plasma levels of osteopontin in patients with restenosis after percutaneous coronary intervention. Kato R., Momiyama Y., Ohmori R., Tanaka N., Taniguchi H., Arakawa K., Kusuhara M., Nakamura H., Ohsuzu F. Arterioscler. Thromb. Vasc. Biol. 26:e1-2(2006) · Mapped (10) |
| Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages. Ayaori M., Sawada S., Yonemura A., Iwamoto N., Ogura M., Tanaka N., Nakaya K., Kusuhara M., Nakamura H., Ohsuzu F. Arterioscler. Thromb. Vasc. Biol. 26:163-168(2006) · Mapped (16) |
| HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b. Shimizu N., Ouchida R., Yoshikawa N., Hisada T., Watanabe H., Okamoto K., Kusuhara M., Handa H., Morimoto C., Tanaka H. Proc. Natl. Acad. Sci. U.S.A. 102:8555-8560(2005) · UniProtKB (2) · Mapped (1) |
| Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. Isoda K., Sawada S., Ayaori M., Matsuki T., Horai R., Kagata Y., Miyazaki K., Kusuhara M., Okazaki M., Matsubara O. et al. J. Biol. Chem. 280:7002-7009(2005) · Mapped (2) |
| Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Isoda K., Sawada S., Ishigami N., Matsuki T., Miyazaki K., Kusuhara M., Iwakura Y., Ohsuzu F. Arterioscler. Thromb. Vasc. Biol. 24:1068-1073(2004) · Mapped (19) |
| Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Isoda K., Shiigai M., Ishigami N., Matsuki T., Horai R., Nishikawa K., Kusuhara M., Nishida Y., Iwakura Y., Ohsuzu F. Circulation 108:516-518(2003) · Mapped (6) |
| Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells. Ouchida R., Kusuhara M., Shimizu N., Hisada T., Makino Y., Morimoto C., Handa H., Ohsuzu F., Tanaka H. |
| Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Isoda K., Kamezawa Y., Ayaori M., Kusuhara M., Tada N., Ohsuzu F. Circulation 107:679-681(2003) · Mapped (11) |
| Osteopontin plays an important role in the development of medial thickening and neointimal formation. Isoda K., Nishikawa K., Kamezawa Y., Yoshida M., Kusuhara M., Moroi M., Tada N., Ohsuzu F. Circ. Res. 91:77-82(2002) · Mapped (14) |
| Killing of naive T cells by CD95L-transfected dendritic cells (DC): in vivo study using killer DC-DC hybrids and CD4(+) T cells from DO11.10 mice. Kusuhara M., Matsue K., Edelbaum D., Loftus J., Takashima A., Matsue H. Eur. J. Immunol. 32:1035-1043(2002) · Mapped (4) |
| Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., Lee J.D. J. Biol. Chem. 271:16586-16590(1996) · Mapped (4) |